【elven swords from lord of the rings】Morgan Stanley: Moderna Has Significant Competitive Advantage
Moderna Inc
(NASDAQ:
MRNA
),elven swords from lord of the rings a messenger RNA therapeutics company, recently offered 26.28 million shares priced at $23 each in an
IPO
.
The Analyst
Morgan Stanley analyst Matthew Harrison initiated coverage of
Moderna
with an Overweight rating and $29 price target.
The Thesis
Moderna has significant competitive advantages given its multibillion-dollar opportunity, a broad pipeline, an industrialized approach and key platform derisking in terms of immunogenicity, delivery and initial proof-of-concept, Harrison said in a Wednesday note.
MRNA addresses almost two-thirds of all proteins in the body, and Moderna has built a broad industrialized platform to address mRNA therapeutics, the analyst said.
Moderna's pipeline is broad, with 21 programs. If the entire pipeline is successful, the company could achieve peak sales as high as $35 billion, Harrison said,
Harrison estimates peak, risk-adjusted sales of $8 billion from prophylactic vaccines, rare diseases and cancer vaccines.
Moderna has managed to resolve the two key challenges in developing mRNA therapeutics: the body's rejection of mRNA and the inability to send the mRNA to target tissues, the analyst said.
The platform risk is therefore significantly diminished, he said.
Morgan Stanley sees the following as key catalysts for specific programs:
Initial data for chikungunya antibody expected in 2020.
Initial PIV3 and CMV immunogenicity data likely in 2019.
Initial data for key rare disease programs due in 2020.
Randomized data for personal cancer vaccines due in 2020.
Even if an individual program fails due to biological reasons, the overall platform is unlikely to be impacted, Harrison said.
The Price Action
Moderna shares were up 0.39 percent at $15.33 at the time of publication Wednesday.
Related Links:
Attention Biotech Investors: Mark Your Calendar For These January PDUFA Dates
6 Valuable Pipeline Drugs With Upcoming Catalysts
Latest Ratings for MRNA
Jan 2019
PiperJaffray
Initiates Coverage On
Overweight
Jan 2019
JP Morgan
Initiates Coverage On
Overweight
Jan 2019
Oppenheimer
Initiates Coverage On
Outperform
View More Analyst Ratings for MRNA
View the Latest Analyst Ratings
See more from Benzinga
The Daily Biotech Pulse: Tracon Aces Early-Stage Trials, Boston Scientific To Buy Out Millipede
The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
View comments
下一篇:The Global Virtualization in Industrial Automation Market is expected to grow by $ 216.39 mn during 2020-2024 progressing at a CAGR of 4% during the forecast period
相关文章:
- Ramping up COVID-19 testing earlier would have helped the UK, top adviser says
- US warns 7 companies over fraudulent coronavirus claims
- INVESTOR ALERT: Kirby McInerney LLP Continues Investigation of Shareholder Claims Against Hallmark Financial Services Inc.
- U.S. SEC eases crowdfunding rules for firms due to coronavirus disruption
- Which Consumer Staples Stock Will Grow The Most By 2025?
- The Zacks Analyst Blog Highlights: Telenav, Forestar, Alpine Income Property Trust, Innovative Industrial Properties and MDU Resources
- ECB working on lending scheme for coronavirus-hit SMEs -sources
- SINGLE STOCK SYMBOL ALERT: The Schall Law Firm Announces it is Investigating Claims Against Tupperware Brands Corporation and Encourages Investors with Losses In Excess of $100,000 to Contact the Firm
- Broadcom Inc. (AVGO) Stock Moves -1.58%: What You Should Know
- What Is Parker-Hannifin's (NYSE:PH) P/E Ratio After Its Share Price Tanked?
相关推荐:
- TAL EDUCATION INVESTOR ALERT: National Litigation Firm Labaton Sucharow Announces Investigation of TAL Education Group (TAL) and Strongly Encourages Stock, Options, Derivative Investors with Losses to Contact the Firm
- Coronavirus fears spark 'panic buying' of toilet paper, water, hand sanitizer. Here's why we all need to calm down
- A Sliding Share Price Has Us Looking At Rexnord Corporation's (NYSE:RXN) P/E Ratio
- Sun Summit Minerals Phase 2 Drilling Update and Completion of IP Survey at the Buck Property
- How to Time the Markets Like an Investing Pro - April 01, 2020
- Coronavirus fears spark 'panic buying' of toilet paper, water, hand sanitizer. Here's why we all need to calm down
- eXp World Holdings Appoints Fee Gentry to Board of Directors
- Oil's Recovery Could Take Decades, Not Years
- StepStone Real Estate Adds Margaret McKnight as Partner
- Monterey Minerals Provides Update on Drill Program
- Pan Global Resources Intersects Near Surface Copper Sulphides in New Drill Holes at the Escacena Project, Spain
- Gilead Sciences Could Be the First to Beat the Coronavirus
- Euro zone yields rise as investors turn cautious on economic outlook
- (APC) INVESTOR ALERT - Anadarko Petroleum Corporation - Bronstein, Gewirtz & Grossman, LLC Notifies Investors With Losses Exceeding $100K of Class Action and Lead Plaintiff Deadline: April 20, 2020
- Why Prosperity Bancshares (PB) is a Top Dividend Stock for Your Portfolio
- Crude Oil Price Update – Needs to Hold Major 50% Level at $36.07 to Sustain Upside Momentum
- Donaldson (DCI) Q1 Earnings & Sales Top Estimates, Decline Y/Y
- The Returns At Treatt (LON:TET) Provide Us With Signs Of What's To Come
- Ex-Tesla employee agrees to pay $400K over claims he stole trade secrets
- Intrepid Congratulates East Plant Employees on Record Monthly Domestic Sales Volumes in April